Urological cancer surgery Surgery Malignant neoplasms of urinary tract
Conditions
Interventions
Patients will be recruited into either surgery for standard robotic surgery (Group A) or surgery supplemented by CTM (Group B), where surgeons from connected hospitals will mentor chosen stages, that
Sponsors
Intuitive Surgical Inc. (USA)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male or female aged =18 years 2. Able to provide written informed consent 3. Diagnosis of urological cancer amenable to curative surgery
Exclusion criteria
Exclusion criteria: 1. Age <18 2. Inability to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Operation time, broken down into defined stages - these will be measured at the time of the operation and recorded. 2. Effect of CTM on learning curve defined outcomes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Positive surgical margin rates. - these will be recorded within 3 months from histology 2. Lymph Node (LN) yields.- these will be recorded within 3 months from histology 3. Functional outcomes (continence and erectile dysfunction rates). Will be measured at 3, 6 and 12 months. 4. Blood loss - will be recorded at time of the operation. 5. Complication rates using Clavien classification - will be recorded at 30 days and 90 days 6. Conversion rates: conversion to open surgery (as an indicator of technical difficulty). Conversion is defined as the need to use a laparotomy wound for any reason other than specimen retrieval - will be recorded at time of surgery. 7. Cost analysis of reduced learning curves - these results will come from the analysis of the times taken to complete the operations. | — |
Countries
United Kingdom
Outcome results
None listed